Hereditary transthyretin (hATTR) amyloidosis is a rare, systemic, progressive, and life-threatening disease in which transthyretin (TTR) proteins misfold and aggregate as insoluble amyloid deposits, disrupting nervous, cardiac, and other organ tissues throughout the body [1, 2]. This evidence concerns the gene TTR and prealbumin measurement.